Drug Shortage Report for ESTRADOT 25
Report ID | 169233 |
Drug Identification Number | 02245676 |
Brand name | ESTRADOT 25 |
Common or Proper name | ESTRADOT TTS-25 0.39MG |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ESTRADIOL |
Strength(s) | 25MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 8 X 1 |
ATC code | G03CA |
ATC description | ESTROGENS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-09-14 |
Actual start date | 2022-09-14 |
Estimated end date | 2022-10-03 |
Actual end date | 2022-10-04 |
Shortage status | Resolved |
Updated date | 2022-10-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-10-13 | French | Compare |
v8 | 2022-10-13 | English | Compare |
v7 | 2022-09-29 | French | Compare |
v6 | 2022-09-29 | English | Compare |
v5 | 2022-09-26 | French | Compare |
v4 | 2022-09-26 | English | Compare |
v3 | 2022-09-15 | English | Compare |
v2 | 2022-09-14 | French | Compare |
v1 | 2022-09-14 | English | Compare |
Showing 1 to 9 of 9